Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['rcc,(-irccs),(-srcc),(-urcc)']
brilliant discussion by about the uncertainties in the field of #systemic therapy for localized rcc. a lot of questions remain to be answered. #esmo22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid